-
XW00 Skin
-
XW000 Open
-
XW0000 Brexanolone
-
XW0000 Spesolimab Monoclonal Antibody
-
XW0001 Daratumumab and Hyaluronidase-fihj
-
XW0001 Eladocagene exuparvovec
-
XW0002 Bromelain-enriched Proteolytic Enzyme
-
XW0002 Nerinitide
-
XW0003 Durvalumab Antineoplastic
-
XW0003 Maribavir Anti-infective
-
XW0004 Teclistamab Antineoplastic
-
XW0005 Mosunetuzumab Antineoplastic
-
XW0005 Narsoplimab Monoclonal Antibody
-
XW0006 Afamitresgene Autoleucel Immunotherapy
-
XW0006 Lefamulin Anti-infective
-
XW0006 Terlipressin
-
XW0007 Coagulation Factor Xa, Inactivated
-
XW0007 Tabelecleucel Immunotherapy
-
XW0007 Trilaciclib
-
XW0008 Lurbinectedin
-
XW0008 Mineral-based Topical Hemostatic Agent
-
XW0008 Treosulfan
-
XW0008 Uridine Triacetate
-
XW0009 Ceftolozane/Tazobactam Anti-infective
-
XW0009 Inebilizumab-cdon
-
XW0009 Satralizumab-mwge
-
XW000A Cefiderocol Anti-infective
-
XW000A Ciltacabtagene Autoleucel
-
XW000B Amivantamab Monoclonal Antibody
-
XW000B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW000B Omadacycline Anti-infective
-
XW000C Eculizumab
-
XW000C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW000D Atezolizumab Antineoplastic
-
XW000D Engineered Allogeneic Thymus Tissue
-
XW000E Etesevimab Monoclonal Antibody
-
XW000E Remdesivir Anti-infective
-
XW000F Bamlanivimab Monoclonal Antibody
-
XW000F Other New Technology Therapeutic Substance
-
XW000G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW000G Plazomicin Anti-infective
-
XW000G REGN-COV2 Monoclonal Antibody
-
XW000G Sarilumab
-
XW000H Axicabtagene Ciloleucel Immunotherapy
-
XW000H Other New Technology Monoclonal Antibody
-
XW000H Synthetic Human Angiotensin II
-
XW000H Tocilizumab
-
XW000J Apalutamide Antineoplastic
-
XW000J Tisagenlecleucel Immunotherapy
-
XW000K Fosfomycin Anti-infective
-
XW000K Idecabtagene Vicleucel Immunotherapy
-
XW000K Leronlimab Monoclonal Antibody
-
XW000L CD24Fc Immunomodulator
-
XW000L Erdafitinib Antineoplastic
-
XW000L Lifileucel Immunotherapy
-
XW000M Baricitinib
-
XW000M Brexucabtagene Autoleucel Immunotherapy
-
XW000M Esketamine Hydrochloride
-
XW000N Lisocabtagene Maraleucel Immunotherapy
-
XW000N Meropenem-vaborbactam Anti-infective
-
XW000P Antibiotic-eluting Bone Void Filler
-
XW000Q Tagraxofusp-erzs Antineoplastic
-
XW000R Fostamatinib
-
XW000R Venetoclax Antineoplastic
-
XW000S COVID-19 Vaccine Dose 1
-
XW000S Iobenguane I-131 Antineoplastic
-
XW000T COVID-19 Vaccine Dose 2
-
XW000T Ruxolitinib
-
XW000U COVID-19 Vaccine
-
XW000U Imipenem-cilastatin-relebactam Anti-infective
-
XW000V COVID-19 Vaccine Dose 3
-
XW000V Gilteritinib Antineoplastic
-
XW000W Caplacizumab
-
XW000W COVID-19 Vaccine Booster
-
XW000X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW000X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW000Y Other New Technology Monoclonal Antibody
-
-
XW003 Percutaneous
-
XW0030 Brexanolone
-
XW0030 Spesolimab Monoclonal Antibody
-
XW0031 Daratumumab and Hyaluronidase-fihj
-
XW0031 Eladocagene exuparvovec
-
XW0032 Bromelain-enriched Proteolytic Enzyme
-
XW0032 Nerinitide
-
XW0033 Durvalumab Antineoplastic
-
XW0033 Maribavir Anti-infective
-
XW0034 Teclistamab Antineoplastic
-
XW0035 Mosunetuzumab Antineoplastic
-
XW0035 Narsoplimab Monoclonal Antibody
-
XW0036 Afamitresgene Autoleucel Immunotherapy
-
XW0036 Lefamulin Anti-infective
-
XW0036 Terlipressin
-
XW0037 Coagulation Factor Xa, Inactivated
-
XW0037 Tabelecleucel Immunotherapy
-
XW0037 Trilaciclib
-
XW0038 Lurbinectedin
-
XW0038 Mineral-based Topical Hemostatic Agent
-
XW0038 Treosulfan
-
XW0038 Uridine Triacetate
-
XW0039 Ceftolozane/Tazobactam Anti-infective
-
XW0039 Inebilizumab-cdon
-
XW0039 Satralizumab-mwge
-
XW003A Cefiderocol Anti-infective
-
XW003A Ciltacabtagene Autoleucel
-
XW003B Amivantamab Monoclonal Antibody
-
XW003B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW003B Omadacycline Anti-infective
-
XW003C Eculizumab
-
XW003C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW003D Atezolizumab Antineoplastic
-
XW003D Engineered Allogeneic Thymus Tissue
-
XW003E Etesevimab Monoclonal Antibody
-
XW003E Remdesivir Anti-infective
-
XW003F Bamlanivimab Monoclonal Antibody
-
XW003F Other New Technology Therapeutic Substance
-
XW003G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW003G Plazomicin Anti-infective
-
XW003G REGN-COV2 Monoclonal Antibody
-
XW003G Sarilumab
-
XW003H Axicabtagene Ciloleucel Immunotherapy
-
XW003H Other New Technology Monoclonal Antibody
-
XW003H Synthetic Human Angiotensin II
-
XW003H Tocilizumab
-
XW003J Apalutamide Antineoplastic
-
XW003J Tisagenlecleucel Immunotherapy
-
XW003K Fosfomycin Anti-infective
-
XW003K Idecabtagene Vicleucel Immunotherapy
-
XW003K Leronlimab Monoclonal Antibody
-
XW003L CD24Fc Immunomodulator
-
XW003L Erdafitinib Antineoplastic
-
XW003L Lifileucel Immunotherapy
-
XW003M Baricitinib
-
XW003M Brexucabtagene Autoleucel Immunotherapy
-
XW003M Esketamine Hydrochloride
-
XW003N Lisocabtagene Maraleucel Immunotherapy
-
XW003N Meropenem-vaborbactam Anti-infective
-
XW003P Antibiotic-eluting Bone Void Filler
-
XW003Q Tagraxofusp-erzs Antineoplastic
-
XW003R Fostamatinib
-
XW003R Venetoclax Antineoplastic
-
XW003S COVID-19 Vaccine Dose 1
-
XW003S Iobenguane I-131 Antineoplastic
-
XW003T COVID-19 Vaccine Dose 2
-
XW003T Ruxolitinib
-
XW003U COVID-19 Vaccine
-
XW003U Imipenem-cilastatin-relebactam Anti-infective
-
XW003V COVID-19 Vaccine Dose 3
-
XW003V Gilteritinib Antineoplastic
-
XW003W Caplacizumab
-
XW003W COVID-19 Vaccine Booster
-
XW003X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW003X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW003Y Other New Technology Monoclonal Antibody
-
-
XW007 Via Natural or Artificial Opening
-
XW0070 Brexanolone
-
XW0070 Spesolimab Monoclonal Antibody
-
XW0071 Daratumumab and Hyaluronidase-fihj
-
XW0071 Eladocagene exuparvovec
-
XW0072 Bromelain-enriched Proteolytic Enzyme
-
XW0072 Nerinitide
-
XW0073 Durvalumab Antineoplastic
-
XW0073 Maribavir Anti-infective
-
XW0074 Teclistamab Antineoplastic
-
XW0075 Mosunetuzumab Antineoplastic
-
XW0075 Narsoplimab Monoclonal Antibody
-
XW0076 Afamitresgene Autoleucel Immunotherapy
-
XW0076 Lefamulin Anti-infective
-
XW0076 Terlipressin
-
XW0077 Coagulation Factor Xa, Inactivated
-
XW0077 Tabelecleucel Immunotherapy
-
XW0077 Trilaciclib
-
XW0078 Lurbinectedin
-
XW0078 Mineral-based Topical Hemostatic Agent
-
XW0078 Treosulfan
-
XW0078 Uridine Triacetate
-
XW0079 Ceftolozane/Tazobactam Anti-infective
-
XW0079 Inebilizumab-cdon
-
XW0079 Satralizumab-mwge
-
XW007A Cefiderocol Anti-infective
-
XW007A Ciltacabtagene Autoleucel
-
XW007B Amivantamab Monoclonal Antibody
-
XW007B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW007B Omadacycline Anti-infective
-
XW007C Eculizumab
-
XW007C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW007D Atezolizumab Antineoplastic
-
XW007D Engineered Allogeneic Thymus Tissue
-
XW007E Etesevimab Monoclonal Antibody
-
XW007E Remdesivir Anti-infective
-
XW007F Bamlanivimab Monoclonal Antibody
-
XW007F Other New Technology Therapeutic Substance
-
XW007G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW007G Plazomicin Anti-infective
-
XW007G REGN-COV2 Monoclonal Antibody
-
XW007G Sarilumab
-
XW007H Axicabtagene Ciloleucel Immunotherapy
-
XW007H Other New Technology Monoclonal Antibody
-
XW007H Synthetic Human Angiotensin II
-
XW007H Tocilizumab
-
XW007J Apalutamide Antineoplastic
-
XW007J Tisagenlecleucel Immunotherapy
-
XW007K Fosfomycin Anti-infective
-
XW007K Idecabtagene Vicleucel Immunotherapy
-
XW007K Leronlimab Monoclonal Antibody
-
XW007L CD24Fc Immunomodulator
-
XW007L Erdafitinib Antineoplastic
-
XW007L Lifileucel Immunotherapy
-
XW007M Baricitinib
-
XW007M Brexucabtagene Autoleucel Immunotherapy
-
XW007M Esketamine Hydrochloride
-
XW007N Lisocabtagene Maraleucel Immunotherapy
-
XW007N Meropenem-vaborbactam Anti-infective
-
XW007P Antibiotic-eluting Bone Void Filler
-
XW007Q Tagraxofusp-erzs Antineoplastic
-
XW007R Fostamatinib
-
XW007R Venetoclax Antineoplastic
-
XW007S COVID-19 Vaccine Dose 1
-
XW007S Iobenguane I-131 Antineoplastic
-
XW007T COVID-19 Vaccine Dose 2
-
XW007T Ruxolitinib
-
XW007U COVID-19 Vaccine
-
XW007U Imipenem-cilastatin-relebactam Anti-infective
-
XW007V COVID-19 Vaccine Dose 3
-
XW007V Gilteritinib Antineoplastic
-
XW007W Caplacizumab
-
XW007W COVID-19 Vaccine Booster
-
XW007X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW007X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW007Y Other New Technology Monoclonal Antibody
-
-
XW008 Via Natural or Artificial Opening Endoscopic
-
XW0080 Brexanolone
-
XW0080 Spesolimab Monoclonal Antibody
-
XW0081 Daratumumab and Hyaluronidase-fihj
-
XW0081 Eladocagene exuparvovec
-
XW0082 Bromelain-enriched Proteolytic Enzyme
-
XW0082 Nerinitide
-
XW0083 Durvalumab Antineoplastic
-
XW0083 Maribavir Anti-infective
-
XW0084 Teclistamab Antineoplastic
-
XW0085 Mosunetuzumab Antineoplastic
-
XW0085 Narsoplimab Monoclonal Antibody
-
XW0086 Afamitresgene Autoleucel Immunotherapy
-
XW0086 Lefamulin Anti-infective
-
XW0086 Terlipressin
-
XW0087 Coagulation Factor Xa, Inactivated
-
XW0087 Tabelecleucel Immunotherapy
-
XW0087 Trilaciclib
-
XW0088 Lurbinectedin
-
XW0088 Mineral-based Topical Hemostatic Agent
-
XW0088 Treosulfan
-
XW0088 Uridine Triacetate
-
XW0089 Ceftolozane/Tazobactam Anti-infective
-
XW0089 Inebilizumab-cdon
-
XW0089 Satralizumab-mwge
-
XW008A Cefiderocol Anti-infective
-
XW008A Ciltacabtagene Autoleucel
-
XW008B Amivantamab Monoclonal Antibody
-
XW008B Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW008B Omadacycline Anti-infective
-
XW008C Eculizumab
-
XW008C Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW008D Atezolizumab Antineoplastic
-
XW008D Engineered Allogeneic Thymus Tissue
-
XW008E Etesevimab Monoclonal Antibody
-
XW008E Remdesivir Anti-infective
-
XW008F Bamlanivimab Monoclonal Antibody
-
XW008F Other New Technology Therapeutic Substance
-
XW008G Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW008G Plazomicin Anti-infective
-
XW008G REGN-COV2 Monoclonal Antibody
-
XW008G Sarilumab
-
XW008H Axicabtagene Ciloleucel Immunotherapy
-
XW008H Other New Technology Monoclonal Antibody
-
XW008H Synthetic Human Angiotensin II
-
XW008H Tocilizumab
-
XW008J Apalutamide Antineoplastic
-
XW008J Tisagenlecleucel Immunotherapy
-
XW008K Fosfomycin Anti-infective
-
XW008K Idecabtagene Vicleucel Immunotherapy
-
XW008K Leronlimab Monoclonal Antibody
-
XW008L CD24Fc Immunomodulator
-
XW008L Erdafitinib Antineoplastic
-
XW008L Lifileucel Immunotherapy
-
XW008M Baricitinib
-
XW008M Brexucabtagene Autoleucel Immunotherapy
-
XW008M Esketamine Hydrochloride
-
XW008N Lisocabtagene Maraleucel Immunotherapy
-
XW008N Meropenem-vaborbactam Anti-infective
-
XW008P Antibiotic-eluting Bone Void Filler
-
XW008Q Tagraxofusp-erzs Antineoplastic
-
XW008R Fostamatinib
-
XW008R Venetoclax Antineoplastic
-
XW008S COVID-19 Vaccine Dose 1
-
XW008S Iobenguane I-131 Antineoplastic
-
XW008T COVID-19 Vaccine Dose 2
-
XW008T Ruxolitinib
-
XW008U COVID-19 Vaccine
-
XW008U Imipenem-cilastatin-relebactam Anti-infective
-
XW008V COVID-19 Vaccine Dose 3
-
XW008V Gilteritinib Antineoplastic
-
XW008W Caplacizumab
-
XW008W COVID-19 Vaccine Booster
-
XW008X Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW008X Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW008Y Other New Technology Monoclonal Antibody
-
-
XW00X External
-
XW00X0 Brexanolone
-
XW00X0 Spesolimab Monoclonal Antibody
-
XW00X1 Daratumumab and Hyaluronidase-fihj
-
XW00X1 Eladocagene exuparvovec
-
XW00X2 Bromelain-enriched Proteolytic Enzyme
-
XW00X27Introduction of Bromelain-enriched Proteolytic Enzyme into Skin, External Approach, New Technology Group 7
-
-
XW00X2 Nerinitide
-
XW00X27Introduction of Bromelain-enriched Proteolytic Enzyme into Skin, External Approach, New Technology Group 7
-
-
XW00X3 Durvalumab Antineoplastic
-
XW00X3 Maribavir Anti-infective
-
XW00X4 Teclistamab Antineoplastic
-
XW00X5 Mosunetuzumab Antineoplastic
-
XW00X5 Narsoplimab Monoclonal Antibody
-
XW00X6 Afamitresgene Autoleucel Immunotherapy
-
XW00X6 Lefamulin Anti-infective
-
XW00X6 Terlipressin
-
XW00X7 Coagulation Factor Xa, Inactivated
-
XW00X7 Tabelecleucel Immunotherapy
-
XW00X7 Trilaciclib
-
XW00X8 Lurbinectedin
-
XW00X8 Mineral-based Topical Hemostatic Agent
-
XW00X8 Treosulfan
-
XW00X8 Uridine Triacetate
-
XW00X9 Ceftolozane/Tazobactam Anti-infective
-
XW00X9 Inebilizumab-cdon
-
XW00X9 Satralizumab-mwge
-
XW00XA Cefiderocol Anti-infective
-
XW00XA Ciltacabtagene Autoleucel
-
XW00XB Amivantamab Monoclonal Antibody
-
XW00XB Cytarabine and Daunorubicin Liposome Antineoplastic
-
XW00XB Omadacycline Anti-infective
-
XW00XC Eculizumab
-
XW00XC Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Autologous
-
XW00XD Atezolizumab Antineoplastic
-
XW00XD Engineered Allogeneic Thymus Tissue
-
XW00XE Etesevimab Monoclonal Antibody
-
XW00XE Remdesivir Anti-infective
-
XW00XF Bamlanivimab Monoclonal Antibody
-
XW00XF Other New Technology Therapeutic Substance
-
XW00XG Engineered Chimeric Antigen Receptor T-cell Immunotherapy, Allogeneic
-
XW00XG Plazomicin Anti-infective
-
XW00XG REGN-COV2 Monoclonal Antibody
-
XW00XG Sarilumab
-
XW00XH Axicabtagene Ciloleucel Immunotherapy
-
XW00XH Other New Technology Monoclonal Antibody
-
XW00XH Synthetic Human Angiotensin II
-
XW00XH Tocilizumab
-
XW00XJ Apalutamide Antineoplastic
-
XW00XJ Tisagenlecleucel Immunotherapy
-
XW00XK Fosfomycin Anti-infective
-
XW00XK Idecabtagene Vicleucel Immunotherapy
-
XW00XK Leronlimab Monoclonal Antibody
-
XW00XL CD24Fc Immunomodulator
-
XW00XL Erdafitinib Antineoplastic
-
XW00XL Lifileucel Immunotherapy
-
XW00XM Baricitinib
-
XW00XM Brexucabtagene Autoleucel Immunotherapy
-
XW00XM Esketamine Hydrochloride
-
XW00XN Lisocabtagene Maraleucel Immunotherapy
-
XW00XN Meropenem-vaborbactam Anti-infective
-
XW00XP Antibiotic-eluting Bone Void Filler
-
XW00XQ Tagraxofusp-erzs Antineoplastic
-
XW00XR Fostamatinib
-
XW00XR Venetoclax Antineoplastic
-
XW00XS COVID-19 Vaccine Dose 1
-
XW00XS Iobenguane I-131 Antineoplastic
-
XW00XT COVID-19 Vaccine Dose 2
-
XW00XT Ruxolitinib
-
XW00XU COVID-19 Vaccine
-
XW00XU Imipenem-cilastatin-relebactam Anti-infective
-
XW00XV COVID-19 Vaccine Dose 3
-
XW00XV Gilteritinib Antineoplastic
-
XW00XW Caplacizumab
-
XW00XW COVID-19 Vaccine Booster
-
XW00XX Broad Consortium Microbiota-based Live Biotherapeutic Suspension
-
XW00XX Tixagevimab and Cilgavimab Monoclonal Antibody
-
XW00XY Other New Technology Monoclonal Antibody
-
-